111 related articles for article (PubMed ID: 36149139)
1. Efficacy of vorinostat-sensitized intraperitoneal radioimmunotherapy with
Tachibana T; Yoshii Y; Matsumoto H; Zhang MR; Nagatsu K; Hihara F; Igarashi C; Sugyo A; Tsuji AB; Higashi T
J Cancer Res Ther; 2022; 18(4):907-914. PubMed ID: 36149139
[TBL] [Abstract][Full Text] [Related]
2.
Yoshii Y; Matsumoto H; Yoshimoto M; Oe Y; Zhang MR; Nagatsu K; Sugyo A; Tsuji AB; Higashi T
J Nucl Med; 2019 Oct; 60(10):1437-1443. PubMed ID: 30850497
[TBL] [Abstract][Full Text] [Related]
3. Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with
Yoshii Y; Yoshimoto M; Matsumoto H; Tashima H; Iwao Y; Takuwa H; Yoshida E; Wakizaka H; Yamaya T; Zhang MR; Sugyo A; Hanadate S; Tsuji AB; Higashi T
Oncotarget; 2018 Jun; 9(48):28935-28950. PubMed ID: 29989003
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized
Hihara F; Matsumoto H; Yoshimoto M; Masuko T; Endo Y; Igarashi C; Tachibana T; Shinada M; Zhang MR; Kurosawa G; Sugyo A; Tsuji AB; Higashi T; Kurihara H; Ueno M; Yoshii Y
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628616
[TBL] [Abstract][Full Text] [Related]
5. Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
Song IH; Lee TS; Park YS; Lee JS; Lee BC; Moon BS; An GI; Lee HW; Kim KI; Lee YJ; Kang JH; Lim SM
J Nucl Med; 2016 Jul; 57(7):1105-11. PubMed ID: 26917708
[TBL] [Abstract][Full Text] [Related]
6. The role of p53 in combination radioimmunotherapy with 64Cu-DOTA-cetuximab and cisplatin in a mouse model of colorectal cancer.
Guo Y; Parry JJ; Laforest R; Rogers BE; Anderson CJ
J Nucl Med; 2013 Sep; 54(9):1621-9. PubMed ID: 23873478
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal disease.
Milenic DE; Baidoo KE; Kim YS; Brechbiel MW
MAbs; 2015; 7(1):255-64. PubMed ID: 25587678
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma.
Saelen MG; Ree AH; Kristian A; Fleten KG; Furre T; Hektoen HH; Flatmark K
Radiat Oncol; 2012 Sep; 7():165. PubMed ID: 23017053
[TBL] [Abstract][Full Text] [Related]
9. Locoregional therapy with α-emitting trastuzumab against peritoneal metastasis of human epidermal growth factor receptor 2-positive gastric cancer in mice.
Li HK; Morokoshi Y; Nagatsu K; Kamada T; Hasegawa S
Cancer Sci; 2017 Aug; 108(8):1648-1656. PubMed ID: 28514062
[TBL] [Abstract][Full Text] [Related]
10. Establishing a peritoneal dissemination xenograft mouse model for survival outcome assessment of experimental gastric cancer.
Zhang C; Awasthi N; Schwarz MA; Schwarz RE
J Surg Res; 2013 Jun; 182(2):227-34. PubMed ID: 23201270
[TBL] [Abstract][Full Text] [Related]
11. Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
Caponigro F; Di Gennaro E; Ionna F; Longo F; Aversa C; Pavone E; Maglione MG; Di Marzo M; Muto P; Cavalcanti E; Petrillo A; Sandomenico F; Maiolino P; D'Aniello R; Botti G; De Cecio R; Losito NS; Scala S; Trotta A; Zotti AI; Bruzzese F; Daponte A; Calogero E; Montano M; Pontone M; De Feo G; Perri F; Budillon A
BMC Cancer; 2016 Nov; 16(1):918. PubMed ID: 27884140
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of radiation-induced DNA repair and prosurvival pathways contributes to vorinostat-mediated radiosensitization of pancreatic cancer cells.
Deorukhkar A; Shentu S; Park HC; Diagaradjane P; Puduvalli V; Aggarwal B; Guha S; Krishnan S
Pancreas; 2010 Nov; 39(8):1277-83. PubMed ID: 20531243
[TBL] [Abstract][Full Text] [Related]
13. Immuno-PET imaging based radioimmunotherapy in head and neck squamous cell carcinoma model.
Song IH; Noh Y; Kwon J; Jung JH; Lee BC; Kim KI; Lee YJ; Kang JH; Rhee CS; Lee CH; Lee TS; Choi IJ
Oncotarget; 2017 Nov; 8(54):92090-92105. PubMed ID: 29190900
[TBL] [Abstract][Full Text] [Related]
14. Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma.
Niu G; Sun X; Cao Q; Courter D; Koong A; Le QT; Gambhir SS; Chen X
Clin Cancer Res; 2010 Apr; 16(7):2095-105. PubMed ID: 20215534
[TBL] [Abstract][Full Text] [Related]
15. Redox-sensitive iodinated polymersomes carrying histone deacetylase inhibitor as a dual-functional nano-radiosensitizer for enhanced radiotherapy of breast cancer.
Zhu Z; Wu M; Sun J; Huangfu Z; Yin L; Yong W; Sun J; Wang G; Meng F; Zhong Z
Drug Deliv; 2021 Dec; 28(1):2301-2309. PubMed ID: 34730060
[TBL] [Abstract][Full Text] [Related]
16. Prior exposure of pancreatic tumors to [sorafenib + vorinostat] enhances the efficacy of an anti-PD-1 antibody.
Booth L; Roberts JL; Poklepovic A; Dent P
Cancer Biol Ther; 2019; 20(1):109-121. PubMed ID: 30142009
[TBL] [Abstract][Full Text] [Related]
17. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S
Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of histone deacetylase inhibitor activity in a phase 1 combined-modality study with radiotherapy.
Ree AH; Saelen MG; Kalanxhi E; Østensen IH; Schee K; Røe K; Abrahamsen TW; Dueland S; Flatmark K
PLoS One; 2014; 9(2):e89750. PubMed ID: 24587009
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antitumor activity of cetuximab in human gastric cancer cell lines in relation to epidermal growth factor receptor (EGFR) expression and mutational phenotype.
Hotz B; Keilholz U; Fusi A; Buhr HJ; Hotz HG
Gastric Cancer; 2012 Jul; 15(3):252-64. PubMed ID: 22011788
[TBL] [Abstract][Full Text] [Related]
20. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci.
Munshi A; Tanaka T; Hobbs ML; Tucker SL; Richon VM; Meyn RE
Mol Cancer Ther; 2006 Aug; 5(8):1967-74. PubMed ID: 16928817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
